Moreover, a high expression level of the CD5 marker was found in B-CLL and MCL patients (79.89 ± 13.2 and 86.7 ± 9.6, respectively), although atypical B-CLL patients expressed a lower level of this marker (45.5 ± 27.0). This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.